TABLETE DE DOSE UNITÁRIA, LIMPADOR DE SUPERFÍCIES RÍGIDAS E PROCESSO PARA LIMPEZA DE UMA SUPERFÍCIE
A unit dose tablet with alkyl cocoyl taurate, alkylaryl sulfonates, and soluble disintegrants addresses the challenge of high detergent content and rapid dissolution, offering effective hard surface cleaning.
Patent Information
- Application Number
- BR112025023391
- Authority / Receiving Office
- BR · BR
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-04-28
- Filing Date
- 2024-04-25
- Publication Date
- 2026-11-10
AI Technical Summary
Existing cleaning tablets face challenges in achieving a high detergent content while maintaining rigidity for transport and storage, yet dissolving rapidly in water, with conventional methods leading to either slow dissolution or inadequate resistance.
A unit dose tablet formulation comprising anionic surfactants like alkyl cocoyl taurate, hydrotropes such as alkylaryl sulfonates, and disintegrants with high solubility, ensuring rapid disintegration in water to form a liquid cleaning composition.
The tablet achieves rapid dissolution in water, providing a clear cleaning solution with improved cleaning effectiveness and resistance to breakage during handling, suitable for hard surface cleaning applications.
Abstract
Description
1 / 18 Single-dose tablet, hard surface cleaner and process for cleaning a surface. Field of Invention
[0001] The present invention is in the field of cleaning compositions. Specifically, it relates to a single-dose tablet that provides a liquid cleaning composition by dissolving in water. Background of the Invention
[0002] Consumers spend a considerable amount of time and effort cleaning their homes. They prefer to use different cleaning products depending on the surfaces to be cleaned. Typically, such products differ in terms of their ingredients, such as detergents, complexing agents, fragrance, etc. Additionally, a specific product may be available in different formats, such as powder, liquid, tablet, and capsule. Consumers generally prefer a product in tablet form, as a tablet has a compact size and provides controlled dosage.
[0003] Typically, a cleaning product in tablet form contains a cleaning concentrate or detergent active ingredient. The consumer dissolves the tablet in water to form a cleaning composition and then uses it. Conventionally, a tablet is formed by compacting a homogenized powder containing the necessary components. On the one hand, a high compression force results in a hard tablet that does not dissolve quickly. On the other hand, lower compression force leads to loosely packed ingredients, which aids in faster dissolution but lacks the necessary resistance. In the present context, it is desirable that the tablet be hard enough to resist breakage during transport / storage, but dissolve quickly when in contact with water.
[0004] In addition, it is implicitly desired that the tablet provide improved cleaning effectiveness. One way to achieve this is by increasing the amount of detergent active in the tablet. However, this may result in Petition 870250098419, dated 10 / 28 / 2025, page 7 / 54 2 / 18 densely packed rigid tablets with a relatively slower dissolution rate. Furthermore, the increased detergent content is offset by a reduction in the amount of disintegrants, thus further affecting dissolution.
[0005] In this regard, document WO 08 / 8040151 describes a solid synthetic detergent comprising anionic surfactants, disintegrants and complexing agents, wherein at least one surfactant surrounding the particles comprising detergent compounds acts as a disintegrating component, and the disintegrants also include polyvinylpyrrolidone, succinic acid or citric acid, and sodium bicarbonate.
[0006] US patent 2002 082187 describes an effervescent compound that includes a solvent and an effervescent system. The solvent may include a glycol ether, for example, but not limited to, 2-butoxyethanol. The effervescent system used in the effervescent compound may be, for example, but not limited to, expanded sodium perborate or a mixture of sodium bicarbonate, sodium carbonate, and an acid.
[0007] US patent 2005 / 0148488 (Henkel, 2005) describes a multiphase detergent tablet having at least one active phase containing one or more washing or cleaning substances, a solid matrix surrounding the substances in the form of a solidified melt, wherein the matrix material is selected from sugars, sugar acids, sugar alcohols and any mixtures thereof. The solid matrix has a solubility above 100 g / L at 20 °C and represents at least 10% of the total weight of the active phase.
[0008] Document WO 00 / 27986 (Henkel, 2000) describes detergent tablets, which are characterized by high hardness combined with short disintegration times. Such tablets can be produced by adding fine particle sugar with at least 50% by weight of the sugar particles having a size of less than 400 microns.
[0009] Document CA 2 324 070 A1 (Henke, 2001) discloses compositions containing 60 to 95% by weight of anionic surfactants, 5 to 40% by weight Petition 870250098419, dated 10 / 28 / 2025, page 8 / 54 3 / 18 hydrotrope and 0 to 35% by weight of carrier material(s) that provide detergent tablets with greater resistance to impact and friction.
[0010] Document WO 2022 / 258413 A1 (Unilever, 2022) discloses unit-dose detergent tablets comprising at least 10% by weight of surfactant; and a dissolving aid selected from hydrated monosaccharides, hydrated disaccharides, hydrated oligosaccharides and combinations thereof, wherein the ratio of surfactant to dissolving aid is at least 1:1.5 by weight.
[0011] Despite the state of the art, there continues to be a need for an improved tablet containing a significantly high quantity of detergent active ingredient, which is rigid but dissolves rapidly when in contact with water.
[0012] While working on this, the present inventors surprisingly found that a unit dose tablet comprising an anionic surfactant based on alkyl cocoyl taurate and selected hydrotrope, in the presence of selected disintegrants, rapidly disintegrates in water, thus providing a liquid cleaning composition. Summary of the Invention
[0013] In a first aspect, the present invention provides a unit dose tablet comprising: a) 5 to 80% by weight of a surfactant selected from anionic surfactants, nonionic surfactants, and combinations thereof; b) a hydrotrope comprising an alkylaryl sulfonate having a C1 to C5 alkyl chain; and (c) a disintegrant comprising a water-soluble disintegrant having a solubility of at least 100 g / L in distilled water at 25 °C, wherein the surfactant comprises at least one anionic surfactant that is an alkyl cocoyl taurate.
[0014] In another aspect, the present invention provides a hard surface cleaner obtained by dissolving a tablet in water according to Petition 870250098419, dated 10 / 28 / 2025, page 9 / 54 4 / 18 the first aspect, in which the ratio between the tablet and water is in the range of 1:5 to 1:100 by weight.
[0015] In a further aspect, the present invention provides a process for cleaning a surface, comprising the steps of: a) to provide water in a container; b) add and dissolve in water a tablet according to the first aspect, wherein the ratio between the tablet and water is in the range of 1:50 to 1:1000 by weight, thus providing a liquid cleaning composition; and c) Apply the cleaning solution to the surface and clean it.
[0016] These and other aspects, characteristics and advantages will become evident to those skilled in the art from reading the detailed description below. Detailed Description of the Invention
[0017] For the avoidance of doubt, any feature of one aspect of the present invention may be applied to any other aspect of the invention. The word “comprising” is intended to mean “including,” but not necessarily “consisting of” or “composed of.” In other words, the steps or options listed need not be exhaustive. Note that the examples presented in the description below are intended to clarify the invention and are not intended to limit the invention to those examples per se. Similarly, all percentages are weight / weight percentages unless otherwise indicated. Except in operational and comparative examples, or where explicitly indicated otherwise, all numbers in this description that indicate quantities of material or reaction conditions, physical or material properties and / or use, should be understood as modified by the word “about.” Numerical ranges expressed in the format “of xay” are understood to include x and y.When multiple preferred ranges are described in "xay" format for a specific feature, it is understood that all ranges that combine the different endpoints are also included. Petition 870250098419, dated 10 / 28 / 2025, page 10 / 54 5 / 18
[0018] The term “unit dose”, as used herein, means a quantity of a composition suitable for single use.
[0019] The term “effervescent system” as used herein refers to a compound or combination of two or more compounds that produce effervescence when in contact with water.
[0020] The term “disintegrant” as used here refers to components present in a tablet to accelerate the dissolution of the tablet in water. When in contact with water, these components break or disintegrate the tablet into smaller fragments, thus accelerating dissolution.
[0021] According to the present invention, a tablet is provided comprising a surfactant, a hydrotrope comprising an alkylaryl sulfonate having a C1 to C5 alkyl chain and a disintegrant. The surfactant is selected from anionic surfactants, nonionic surfactants and combinations thereof, wherein the surfactant comprises at least one anionic surfactant that is an alkyl cocoyl taurate.
[0022] Surfactant
[0023] The tablet according to the present invention comprises a surfactant. The tablet comprises from 5 to 80% by weight of the surfactant. Preferably, the amount of surfactant is in the range of 7 to 75% by weight, more preferably from 10 to 70% by weight and, most preferably, from 12 to 65% by weight of the tablet.
[0024] The surfactant in the tablet is selected from anionic surfactants, nonionic surfactants, and combinations thereof.
[0025] Anionic surfactant
[0026] The tablet comprises at least one anionic surfactant which is alkyl cocoyl taurate. It is observed that the alkyl cocoyl taurate, in addition to the hydrotrope, aids in faster dissolution. The alkyl cocoyl taurate may comprise up to 100% by weight of the total amount of anionic surfactant present in the tablet. The alkyl cocoyl taurate may constitute from 50 to 100% by weight of the total amount of surfactant. More preferably, the alkyl cocoyl taurate in the tablet is in Petition 870250098419, dated 10 / 28 / 2025, page 11 / 54 6 / 18 range of 10 to 90% by weight, even more preferably from 20 to 80% by weight, with the most preference being 30 to 75% by weight of the total amount of anionic surfactant. Alkyl cocoyl taurate may constitute 50 to 100% by weight of the total amount of surfactant.
[0027] Preferably, the tablet comprises another anionic surfactant along with the alkyl cocoyl taurate.
[0028] The anionic surfactant suitable for the present invention includes salts of organic sulfates and sulfonates having alkyl radicals containing from about 8 to about 22 carbon atoms, the term “alkyl” being used to include the alkyl portion of higher acyl radicals. Examples of such materials include alkyl sulfates, alkyl ether sulfates, alkyl sulfonates, alpha-olefin sulfonates, and mixtures thereof. The alkyl radicals preferably contain from 10 to 18 carbon atoms and may be unsaturated. Alkyl ether sulfates may contain from one to ten units of ethylene oxide or propylene oxide per molecule and preferably contain from one to three units of ethylene oxide per molecule.
[0029] The suitable anionic surfactant includes alkylbenzene sulfonates. Preferably, in a suitable embodiment for dishwashing, it comprises linear alkylbenzene sulfonate (LAS) with an alkyl chain length of 10 to 18 carbon atoms. Commercial LAS is a mixture of closely related isomers and alkyl chain homologues, each containing a sulfonated aromatic ring in the “para” position and attached to a linear alkyl chain at any position except the terminal carbons. The linear alkyl chain typically has a chain length of 11 to 15 carbon atoms, with the predominant materials having a chain length of about C12. Each alkyl chain homologue consists of a mixture of all possible sulfophenyl isomers except for the 1-phenyl isomer. LAS is generally formulated in acidic compositions, i.e., it forms HLAS and is then at least partially neutralized in situ.The counterion for anionic surfactants is usually an alkali metal such as sodium or... Petition 870250098419, dated 10 / 28 / 2025, p. 12 / 54 7 / 18 potassium; or an ammoniacal counterion such as monoethanolamine (MEA), diethanolamine (DEA) or triethanolamine (TEA), monoisopropanolamine (MIPA), monoisopropylamine. Mixtures of such counterions may also be used. Sodium and potassium are preferred.
[0030] Preferably, the suitable anionic surfactant includes alkyl sulfate surfactant (PAS), such as non-ethoxylated primary and secondary alkyl sulfates with an alkyl chain length of 10 to 18.
[0031] The tablet may contain alkyl ether sulfates having a linear or branched alkyl chain group having 10 to 18, more preferably 12 to 14 carbon atoms and containing an average of 1 to 3 ethylene oxide (EO) units per molecule. A preferred example is sodium lauryl ether sulfate (SLES) in which the C12 lauryl alkyl group has been predominantly ethoxylated with an average of 3 EO units per molecule. Alkyl ether sulfates may be used alone or in combination with any other anionic surfactant. The anionic surfactant in liquid form may be absorbed into an inorganic salt and become available as a free-flowing powder.
[0032] The anionic surfactant may be selected from alkylbenzene sulfonate, alkyl ether sulfate, alkyl cocoyl taurate and combinations thereof. Preferably, the anionic surfactant comprises alkyl cocoyl taurate.
[0033] Preferably, the anionic surfactant is a combination of alkyl cocoyl taurate with at least one selected from alkyl sulfate, alkyl ether sulfate and linear alkylbenzene sulfonate. Most preferably, the alkyl cocoyl taurate is methyl cocoyl taurate and / or its sodium salt.
[0034] The anionic surfactant may comprise up to 100% by weight of the total amount of surfactant present in the tablet. More preferably, the anionic surfactant in the tablet is in the range of 10 to 90% by weight, even more preferably 20 to 80% by weight, with the most preference being 30 to 70% by weight of the total amount of surfactant.
[0035] Preferably, the amount of anionic surfactant present in the tablet is in the range of 5 to 75% by weight. More preferably, the amount of Petition 870250098419, dated 10 / 28 / 2025, page 13 / 54 8 / 18 anionic surfactant in the tablet is in the range of 7.5 to 75% by weight, even more preferably from 10 to 75% by weight, with the most preference being 15 to 75% by weight.
[0036] Non-ionic surfactant
[0037] The tablet according to the present invention may comprise a non-ionic surfactant.
[0038] Suitable nonionic surfactants include water-soluble aliphatic ethoxylated nonionic surfactants, including primary aliphatic alcohol ethoxylates and secondary aliphatic alcohol ethoxylates.This includes the condensation products of a higher alcohol (e.g., an alkanol containing from about 8 to 16 carbon atoms in a linear or branched chain configuration) condensed with about 4 to 20 moles of ethylene oxide, for example, lauryl or myristyl alcohol condensed with about 10 moles of ethylene oxide (EO), tridecanol condensed with about 6 to 15 moles of EO, myristyl alcohol condensed with about 10 moles of EO per mole of myristyl alcohol, the condensation product of EO with a coconut fatty alcohol cut containing a mixture of fatty alcohols with alkyl chains ranging from 10 to about 14 carbon atoms in length and wherein the condensate contains either about 6 moles of EO per mole of total alcohol or about 9 moles of EO per mole of alcohol, and tallow alcohol ethoxylates containing... 6 EO to 11 EO per mole of alcohol.
[0039] Examples of the above nonionic surfactants include, among others, Neodol (registered trademark, ex Shell), which is a higher aliphatic primary alcohol containing about 9 to 15 carbon atoms, such as C9 to C11 alkanols condensed with 4 to 10 moles of ethylene oxide (Neodol 91-8 or Neodol 915), C12 to C13 alkanols condensed with 6.5 moles of ethylene oxide (Neodol 23-6.5), C12 to C15 alkanols condensed with 12 moles of ethylene oxide (Neodol 25-12), C14 to C15 alkanols condensed with 13 moles of ethylene oxide (Neodol 45-13), and the like. Such ethoxamers have an HLB (hydrophobic-lipophilic balance) value of about 8 to 15 and provide good Petition 870250098419, dated 10 / 28 / 2025, p. 14 / 54 9 / 18 O / W emulsification, while ethoxamers with HLB values below 7 contain fewer than 4 ethylene oxide groups and tend to be weak emulsifiers and detergents.
[0040] Another group of suitable nonionic surfactants are alkyl polyglycosides (APGs) which are derived from fatty alcohol sugars. Examples of these surfactants are decyl glucoside, lauryl glucoside, myristyl glucoside.
[0041] Preferably, the amount of non-ionic surfactant present in the tablet is in the range of 5 to 75% by weight. More preferably, the amount of non-ionic surfactant in the tablet is in the range of 7.5 to 75% by weight, even more preferably from 10 to 75% by weight, with the most preference being 15 to 75% by weight.
[0042] The tablet may comprise a combination of anionic surfactant and nonionic surfactant. Preferably, the combination may contain anionic surfactant and nonionic surfactant in a ratio of 5:1 to 5:1 by weight.
[0043] The tablet may additionally comprise a cationic surfactant in addition to the anionic surfactant and / or the nonionic surfactant.
[0044] Suitable cationic surfactants are quaternary ammonium salts. According to the present invention, quaternary ammonium salts are characterized in that the ammonium salt has the general formula: R1R2R3R4N+X, wherein R1 is a C12 to C18 alkyl group, wherein each of R2, R3 and R4 is independently a C1 to C3 alkyl group and X is an inorganic anion. R1 is preferably a linear chain C14 to C16 alkyl group, more preferably C16. R2, R3 and R4 are preferably methyl groups. The inorganic anion (X-) is preferably chosen from halide, sulfate, bisulfate or hydroxide.
[0045] For the purposes of this invention, a quaternary ammonium hydroxide is considered a quaternary ammonium salt. More preferably, the anion is a halide or sulfate ion, most preferably a chloride or Petition 870250098419, dated 10 / 28 / 2025, page 15 / 54 10 / 18 sulfate. Cetyltrimethylammonium chloride is a specific example of a suitable compound that is commercially available in abundant quantities.
[0046] Another type of quaternary ammonium cationic surfactant is the class of benzalkonium halides, also known as alkyldimethylbenzylammonium halides. The most common type is benzalkonium chloride, also known as alkyl-dimethyl-benzyl-ammonium chloride (or ADBAC).
[0047] An amphoteric surfactant may also be present in the tablet in addition to the anionic surfactant and / or the nonionic surfactant.
[0048] Suitable amphoteric surfactants include aliphatic quaternary ammonium derivatives, sulfonium and phosphonium compounds having an aliphatic radical of 8 to 18 carbon atoms and an aliphatic radical substituted by a water-solubilizing anionic group, for example, 3-(NN-dimethyl-Nhexadecylammonium)propane-1-sulfonatobetaine, 3-(dodecylmethylsulfonium)propane-1-sulfonatobetaine and 3-(cetylmethylphosphonium)ethanesulfonatobetaine.
[0049] Examples of amphoteric surfactants suitable for the present invention include cocoamidopropyl betaine (CAPB), cocoamidopropylamine oxide (CAPAO), cocodiethanol amide (CDEA) and cocomonoethanol amide (CMEA).
[0050] Hydrotrope
[0051] The tablet comprises a hydrotrope comprising an alkylaryl sulfonate having a C1 to C5 alkyl chain. It is observed that the hydrotrope in the presence of the selected disintegrant and surfactant accelerates the disintegration of the tablet.
[0052] Hydrotropes are a class of low molecular weight compounds having a hydrophilic and hydrophobic moiety similar to surfactants. However, the hydrophobic moiety is much smaller compared to surfactants. Thus, they cannot lead to spontaneous self-aggregation or micellar solubilization. It is also observed that hydrotropes do not have a critical micelle concentration (CMC) or critical vesicular concentration (CVC) as occurs in Petition 870250098419, dated 10 / 28 / 2025, p. 16 / 54 11 / 18 surfactants. It may be possible for the hydrotrope to aggregate in a stepwise self-aggregation process, gradually increasing the size of the aggregation.
[0053] The tablet preferably comprises from 0.1 to 10% by weight of the hydrotrope. More preferably, the tablet comprises from 0.2 to 9% by weight, even more preferably from 0.3 to 8% by weight and, most preferably, from 0.3 to 7% by weight of the hydrotrope.
[0054] The hydrotrope comprises an alkylaryl sulfonate having a C1 to C5 alkyl chain. The alkylaryl sulfonate may be selected from sodium xylenesulfonate, sodium toluenesulfonate, sodium cumenesulfonate, potassium xylenesulfonate, potassium toluenesulfonate, potassium cumenesulfonate and combinations thereof. Most preferably, the alkylaryl sulfonate hydrotrope is sodium cumenesulfonate and / or sodium xylenesulfonate.
[0055] Disintegrant
[0056] The tablet comprises a disintegrant. The disintegrant in a tablet context is used to facilitate the breaking or disintegration of the tablet into smaller fragments, thus aiding in the dissolution of detergent actives in water. Surprisingly, in the present invention, it is observed that the selected hydrotrope, in the presence of the selected disintegrant and surfactant, aids in the disintegration process.
[0057] Preferably, the tablet comprises 10 to 90% by weight of the disintegrant. More preferably, the tablet comprises 15 to 85% by weight, even more preferably 20 to 80% by weight and, most preferably, 25 to 75% by weight of the disintegrant.
[0058] The disintegrant comprises a water-soluble disintegrant having a solubility of 100 g / L in distilled water at 25 °C. More preferably, the water-soluble disintegrant has a solubility greater than 200 g / L, even more preferably greater than 300 g / L and, most preferably, greater than 400 g / L in distilled water at 25 °C. A tablet containing such disintegrants, when Petition 870250098419, dated 10 / 28 / 2025, page 17 / 54 12 / 18 added to water leaves no residue in the water, thus providing a clear liquid cleaning solution when diluted.
[0059] Preferably, the water-soluble disintegrant is selected from hydrated monosaccharides, hydrated disaccharides, and hydrated oligosaccharides. Most preferably, the water-soluble disintegrant is glucose monohydrate.
[0060] Preferably, the water-soluble disintegrant is present up to at least 50% by weight, more preferably at least 70% by weight, even more preferably at least 80% by weight and, most preferably, at least 90% by weight of the total amount of disintegrant. The tablet may comprise the water-soluble disintegrant in an amount up to 100% by weight of the total disintegrant. Preferably, the water-soluble disintegrant constitutes 50 to 100% by weight of the total amount of disintegrant.
[0061] Preferably, the amount of water-soluble disintegrant is in the range of 10 to 90% by weight of the tablet. More preferably, the amount of water-soluble disintegrant is in the range of 15 to 85% by weight, even more preferably 20 to 80% by weight and, most preferably, 25 to 75% by weight of the tablet.
[0062] The disintegrant may further comprise a water-insoluble disintegrant. The water-soluble disintegrant may be selected from microcrystalline cellulose, sodium starch glycolate, polyvinylpyrrolidone, starch, calcium silicate, magnesium stearate, and combinations thereof. Polyvinylpyrrolidone includes cross-linked polyvinylpyrrolidone.
[0063] The amount of water-insoluble disintegrant, if present, may be in the range of 1 to 60% by weight, more preferably 3 to 50% by weight and, most preferably, 5 to 40% by weight of the tablet.
[0064] Organic acid
[0065] The tablet according to the present invention may comprise an organic acid. Petition 870250098419, dated 10 / 28 / 2025, page 18 / 54 13 / 18
[0066] Preferably, the organic acid is selected from citric acid, tartaric acid, fumaric acid, malic acid, adipic acid, succinic acid, and combinations thereof. Preferably, the organic acid is citric acid.
[0067] Preferably, the tablet comprises 1 to 50% by weight, more preferably 3 to 45% by weight and, most preferably, 5 to 40% by weight of organic acid.
[0068] Inorganic salt soluble in water
[0069] The tablet may comprise a water-soluble inorganic salt. Suitable inorganic salts include alkali metal carbonate or bicarbonate or silicate salts and combinations thereof.
[0070] Preferably, the carbonate or bicarbonate salt is selected from sodium carbonate, potassium carbonate, calcium carbonate, sodium bicarbonate, potassium bicarbonate, calcium carbonate, calcium bicarbonate and magnesium carbonate, as well as mixtures thereof.
[0071] Preferably, the tablet comprises from 1 to 50% by weight, more preferably from 3 to 45% by weight and, most preferably, from 5 to 40% by weight of water-soluble inorganic salt.
[0072] The organic acid and the water-soluble insoluble substance may be selected in a combination that serves as an effervescent source in the tablet. This combination further accelerates the dissolution of the tablet when in contact with water. An example of this combination includes a carbonate / bicarbonate salt with a selected organic acid, such as citric acid. The bicarbonate / carbonate salt and the organic acid may be considered in a ratio of 10:1 to 1:10, more preferably 5:1 to 1:5, with the highest preference being 3:1 to 1:3 by weight. Most preferably, the ratio between the bicarbonate salt and the organic acid or the inorganic acid salt or the inorganic acid salt is 1:1 by weight.
[0073] Kidnapper
[0074] The tablet may comprise a sequestrant. Examples include alkali metal, citrates, succinates, malonates, carboxymethyl succinates, Petition 870250098419, dated 10 / 28 / 2025, page 19 / 54 14 / 18 carboxylates, polycarboxylates, and polyacetyl carboxylates. Specific examples include sodium, potassium, lithium salts of oxydisuccinic acid, melitic acid, polycarboxylic benzene acids, and citric acid. Other examples are DEQUEST™, organic phosphonate-type sequestrants marketed by Monsanto, and alkane-hydroxy phosphonates.
[0075] The tablet may comprise from 0.1 to 6% by weight, more preferably from 0.2 to 5% by weight, even more preferably from 0.3 to 4% by weight and, most preferably, from 0.5 to 3% by weight of the sequestrant. A preferred sequestrant is Dequest®2066 (diethylenetriaminepenta(methylenephosphonic) acid or heptasodium DTPMP). Another suitable sequestrant is 1-hydroxyethylidene-1,1-diphosphonic acid (HEDP) and methylglycinodiacetic acid (MGDA), tetrasodium salt of glutamic acid-diacetic acid (GLDA). Most preferably, the sequestrant is methylglycinodiacetic acid (MGDA) and / or tetrasodium salt of glutamic acid-diacetic acid (GLDA).
[0076] Fracture stress
[0077] It is desirable that the tablet have a certain hardness to resist breakage during handling / transport.
[0078] One of the ways to assess tablet hardness is diametral fracture stress (DFS). The tablet preferably has a diametral fracture stress (DFS) ratio between DFSea / DFWater of at least 6, preferably at least 7, preferably at least 8, more preferably at least 9.
[0079] More preferably, the tablet has a diametral fracture stress ratio (DFS) between DFSea / DFWater in the range of 6 to 50, preferably 7 to 45.
[0080] The DFSar / DFSwater ratio can be measured using techniques known to those skilled in the art. DFS can be measured using a texture analyzer, for example, a Brookfield CT3 Texture Analyzer. For example, the DFSar / DFSwater ratio can be measured using a TA instrument, model Petition 870250098419, dated 10 / 28 / 2025, page 20 / 54 15 / 18 The TA-XT2i and Texture Expert software (Texture Technologies Corp., Scarsdale, NY, USA / Stable Micro Systems, Surrey, England, UK) are used. The instrument is calibrated with a 5 kg load cell and equipped with a flat-bottomed cylindrical stainless steel probe with a surface area of 1 cm² (Kobe probe). The methodology consists of positioning the tablet on the flat surface of the probe. The probe moves until a trigger force is detected, at which point the TA is adjusted to maintain a predetermined nominal force for a given time (60 s). As the tablet begins to disintegrate, the TA measures the penetration distance as the tablet is pressed while submerged in the medium (water). A constant medium temperature of 18 °C is maintained during testing by means of a Thermos double-walled cell and a heating bath / circulator (Haake, Karlsruhe, Germany).
[0081] Application
[0082] The tablet can be formulated for cleaning hard surfaces. The term 'hard surfaces' here includes surfaces in a domestic environment, for example, kitchen utensils, floors, tiles, dishes, kitchen counters, tabletops, etc. Consumers can dose one tablet into a bucket of water and allow it to dissolve, thus forming a cleaning composition. The composition here can be used for cleaning surfaces such as tiles and floors.
[0083] It may also be possible for consumers to dose one tablet into a container or bottle filled with water, and prepare a hard surface cleaner that can be stored and used later.
[0084] The tablet, according to the present invention, can be supplied together with a container having sufficient empty space. Consumers can fill the container with water, preferably up to a predefined mark, and dose the tablet. The tablet dissolves in the water, thus providing a cleaning product. Preferably, the container is clear or translucent, and the composition appears visually transparent. This arrangement generally provides a visual indication to consumers. 'Visually clear' or Petition 870250098419, dated 10 / 28 / 2025, page 21 / 54 16 / 18 'transparent' in the context of the composition refers to a liquid having a turbidity value of less than 50 NTU (Nephelometric Turbidity Unit), more preferably less than 30 NTU, even more preferably 20 NTU and, most preferably, 10 NTU. The container may be fitted with a spray nozzle or foaming motor, which assists in dispensing the cleaning composition directly onto the surface in the form of a spray or foam.
[0085] According to the present invention, a hard surface cleaner is provided by dissolving the tablet in water, wherein the ratio between the tablet and water is in the range of 1:5 to 1:100 by weight. Preferably, the ratio between the tablet and water is in the range of 1:7 to 1:80 by weight, more preferably from 1:9 to 1:60 by weight and, most preferably, from 1:10 to 1:50 by weight. The hard surface cleaner can be obtained by following the steps of taking a container, filling the container with water, dosing the tablet and, optionally, shaking the container. The hard surface cleaner can be stored and used at a later stage. Preferably, the tablet is free of insolubles and the hard surface obtained is transparent. The term 'free from insolubles' here indicates that the tablet contains less than 5% by weight, more preferably less than 3% by weight, even more preferably less than 1% by weight, and most preferably less than 0.5% by weight of insoluble compounds.In a given scenario, the tablet does not contain an insoluble compound. The term 'transparent' here implies that the hard surface cleaner appears to be visually clear or that the liquid has a turbidity value of less than 50 NTU (nephelometric turbidity unit), more preferably less than 30 NTU and, most preferably, less than 10 NTU.
[0086] According to the present invention, a process for cleaning a surface is also provided, which comprises the steps of: providing water in a container or bucket, adding and dissolving the tablet in the water, wherein the ratio between the tablet and water is in the range of 1:50 to 1:1000 by weight, Petition 870250098419, dated 10 / 28 / 2025, page 22 / 54 17 / 18 thus providing a liquid cleaning composition; and apply the cleaning composition to the surface and clean it. Preferably, the ratio of tablet to water is in the range of 1:75 to 1:800 by weight, more preferably 1:100 to 1:600 by weight, with the highest preference being 1:150 to 1:500 by weight. Preferably, the cleaning composition is intended for immediate use and cannot be stored for later use. Consumers may use an applicator or implement, for example, a cloth, wipe, brush, or mop to apply the cleaning composition and, optionally, rinse the surface with water.
[0087] Tablet manufacturing process
[0088] Preferably, the tablets are prepared following the conventional tablet manufacturing process. In this process, a homogenized dry powder is prepared by mixing the ingredients in the specified ratio. Subsequently, the powder is placed in a mold and compressed to form the tablet. A rotary or hydraulic press may be used to compress the powder into a tablet.
[0089] Preferably, the pressure applied during compression is in the range of 1 to 100 kg-f / cm2, more preferably from 2 to 80 kg-f / cm2, even more preferably from 3 to 60 kg-f / cm2, and most preferably from 4 to 50 kgf / cm2. Examples
[0090] Dry powder mixtures were prepared according to the recipes provided in Table 1. In the subsequent step, 10 g of each dry powder mixture was placed in a mold die and compressed by applying a pressure of 5 kg-f / cm2, thus forming the tablet.
[0091] To evaluate the performance of the tablets manufactured by said process, each tablet was added to 350 mL of water and allowed to disintegrate and dissolve. The disintegration time of each tablet was recorded using a stopwatch. The term 'disintegration time' here refers to the time that Petition 870250098419, dated 10 / 28 / 2025, page 23 / 54 18 / 18 the tablet takes to disintegrate into smaller fragments smaller than 1 millimeter (approximately).
[0092] Table 1 Material (% w / w) Example 1 Example A Example B UFARYL DL 80* 5.5 5.5 18.5 Sodium methyl cocoyl taurate 13 13 - Sodium cumenesulfonate 3 - 3 Citric acid 37 37 37 Preservative 5 5 5 Perfume 2 2 2 Colorant 0.01 0.01 0.01 Glucose monohydrate Up to 100 Up to 100 Up to 100 Disintegration time (seconds) -» 111 162 525 * Linear sodium alkylbenzene sulfonate (80% w / w active ingredient) from Unger Fabrikker AS.
[0093] Example 1 conforms to the invention, containing sodium cumenesulfonate as a selected hydrotrope and sodium methyl cocoyl taurate, whereas Examples A and B are comparative. From the table above, it is evident that Example 1 disintegrates significantly faster than Examples A and B. Petition 870250098419, dated 10 / 28 / 2025, page 24 / 54
Claims
1 / 2 Claims 1. Unit dose tablet, characterized by comprising: a) 5 to 80% by weight of a surfactant selected from anionic surfactants, nonionic surfactants and combinations thereof; b) a hydrotrope comprising an alkylaryl sulfonate having a C1 to C5 alkyl chain; and c) a disintegrant comprising a water-soluble disintegrant having a solubility of at least 100 g / L in distilled water at 25 °C, wherein the surfactant comprises at least one anionic surfactant that is an alkyl cocoyl taurate.
2. Tablet, according to claim 1, characterized in that the tablet comprises from 10 to 75% by weight of anionic surfactant.
3. Tablet, according to claim 1 or 2, characterized in that the anionic surfactant is a combination of alkyl cocoyl taurate and at least one selected from primary alkyl sulfate, alkylbenzene sulfonate and alkyl ether sulfate.
4. Tablet, according to any one of claims 1 to 3, characterized by further comprising a nonionic surfactant selected from alcohol ethoxylate, alkyl polyglycoside and combinations thereof.
5. Tablet, according to any one of claims 1 to 4, characterized in that the amount of hydrotrope is in the range of 0.1 to 10% by weight of the tablet.
6. Tablet, according to any one of claims 1 to 5, characterized in that the alkylaryl sulfonate is selected from sodium xylenesulfonate, sodium toluenesulfonate, sodium cumenesulfonate, potassium xylenesulfonate, potassium toluenesulfonate, potassium cumenesulfonate and combinations thereof.
7. Tablet, according to claim 6, characterized in that the alkylaryl sulfonate is sodium cumenesulfonate and / or sodium xylenesulfonate. Petition 870250098419, dated 10 / 28 / 2025, page 25 / 54 2 / 2 8. Tablet, according to any one of claims 1 to 7, characterized in that the amount of disintegrant is in the range of 10 to 90% by weight of the tablet.
9. Tablet, according to claim 8, characterized in that the water-soluble disintegrant constitutes 50 to 100% by weight of the total weight of the disintegrant.
10. Tablet, according to any one of claims 1 to 9, characterized in that the water-soluble disintegrant is selected from hydrated monosaccharides, hydrated disaccharides, hydrated oligosaccharides and combinations thereof.
11. Tablet, according to claim 10, characterized in that the water-soluble disintegrant is glucose monohydrate.
12. Hard surface cleaner, characterized by being obtained by dissolving a tablet, as defined in any one of claims 1 to 11, in water, wherein the ratio between tablet and water is in the range of 1:5 to 1:100 by weight.
13. Process for cleaning a surface, characterized by comprising the steps of: a) providing water in a container; b) adding and dissolving in the water a tablet as defined in any one of claims 1 to 11, wherein the ratio between the tablet and water is in the range of 1:50 to 1:1000 by weight, thus providing a liquid cleaning composition; and c) applying the cleaning composition to the surface and cleaning it. Petition 870250098419, dated 10 / 28 / 2025, page 26 / 54
